Timothy Springer thought his fortune was excessive, even before he became a billionaire.
“I’ve had more than enough wealth for myself for some time,” Springer said in a 2018 interview. “I don’t feel I need more.”
The Harvard University medical professor’s riches are much bigger now, thanks to his stake in Moderna Inc., the US
biotechnology firm attempting to develop a vaccine for the novel coronavirus. Shares in the Cambridge, Massachusetts-based company surged 152 per cent this year through Wednesday, boosting Springer’s net worth to more than $1 billion, according to the Bloomberg Billionaires Index.
biotechnology firm attempting to develop a vaccine for the novel coronavirus. Shares in the Cambridge, Massachusetts-based company surged 152 per cent this year through Wednesday, boosting Springer’s net worth to more than $1 billion, according to the Bloomberg Billionaires Index.
Springer, 72, is among those